To launch a national strategy to support regenerative medicine through funding for research and commercial development of regenerative medicine products and development of a regulatory environment that enables rapid approval of safe and effective products, and for other purposes.
The bill’s titles are written by its sponsor.
Sponsor and status
Sponsor. Representative for California's 50th congressional district. Republican.
Last Updated: May 12, 2011
Length: 15 pages
112th Congress, 2011–2013
This bill was introduced on May 12, 2011, in a previous session of Congress, but was not enacted.
May 12, 2011
Bills and resolutions are referred to committees which debate the bill before possibly sending it on to the whole chamber.
H.R. 1862 (112th) was a bill in the United States Congress.
A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
This bill was introduced in the 112th Congress, which met from Jan 5, 2011 to Jan 3, 2013. Legislation not enacted by the end of a Congress is cleared from the books.
How to cite this information.
We recommend the following MLA-formatted citation when using the information you see here in academic work:
GovTrack.us. (2019). H.R. 1862 — 112th Congress: Regenerative Medicine Promotion Act of 2011. Retrieved from https://www.govtrack.us/congress/bills/112/hr1862
“H.R. 1862 — 112th Congress: Regenerative Medicine Promotion Act of 2011.” www.GovTrack.us. 2011. August 21, 2019 <https://www.govtrack.us/congress/bills/112/hr1862>
Regenerative Medicine Promotion Act of 2011, H.R. 1862, 112th Cong..
|title=H.R. 1862 (112th)
|accessdate=August 21, 2019
|author=112th Congress (2011)
|date=May 12, 2011
|quote=Regenerative Medicine Promotion Act of 2011
Where is this information from?
GovTrack automatically collects legislative information from a variety of governmental and non-governmental sources. This page is sourced primarily from Congress.gov, the official portal of the United States Congress. Congress.gov is generally updated one day after events occur, and so legislative activity shown here may be one day behind. Data via the congress project.